Page last updated: 2024-09-03

sch 23982 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

sch 23982 has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Compound Research Comparison

Studies
(sch 23982)
Trials
(sch 23982)
Recent Studies (post-2010)
(sch 23982)
Studies
(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
Trials
(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
87003,85981,052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hornykiewicz, O; Nanoff, C; Pifl, C; Schingnitz, G; Schütz, W1

Other Studies

1 other study(ies) available for sch 23982 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease.
    Journal of neurochemistry, 1992, Volume: 58, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenylyl Cyclases; Aged; Aged, 80 and over; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Macaca mulatta; Male; Parkinson Disease; Putamen; Receptors, Dopamine; Somatostatin

1992